Berman Tabacco

Nathaniel L. Orenstein

Partner

Nathaniel L. Orenstein

Nathaniel L. Orenstein is a partner in Berman Tabacco’s Boston office. He has dedicated his career to working on behalf of investors and consumers who have been harmed by improper actions by companies, their executives, and/or directors. Skilled in all phases of litigation, Nathaniel works tirelessly on behalf of his clients and the classes they represent, relishing opportunities to demonstrate corporate wrongdoing to juries at trial.

Prior to joining the firm, Nathaniel was the lead attorney on several high-profile securities fraud regulatory actions for the Securities Division of the Office of the Secretary of the Commonwealth of Massachusetts. Before that, while studying law at New York University, Nathaniel was a legal intern in the Investor Protection Bureau of the New York State Office of the Attorney General. Also, while in law school, Nathaniel was president of the Public Interest Law Foundation, raising and awarding thousands of dollars to deserving public interest projects.

Before studying law, Nathaniel was the Associate Director of the Center for Insurance Research, a consumer advocacy organization. In this role he supported complex litigation matters and advanced public policy initiatives involving insurance and banking industries and mutual holding company conversions.

Experience

  • Currently serves as the firm’s lead attorney representing a class of end-payor plaintiffs in In re Asacol Antitrust Litigation, No. 1:15-cv-12730-DJC (D. Mass.) in this product-hop antitrust litigation that is going to trial in late-January 2018.
  • Served as one of the firm’s lead attorneys representing institutional and individual clients in a number of cases involving mergers in which shareholders of the acquired companies received inadequate consideration. These cases include, for example: In re Bluegreen Corporation Shareholder Litigation, Case No. 502011CA018111 (Fla.) (first, increased merger consideration by $75 million, then settled for additional $36.5 million); In re TPC Group Inc. Shareholders Litigation, C.A. No. 7865 (Del. Ch.) (increased merger consideration by $79 million); In re El Paso Corporation Shareholder Litigation, C.A. No. 6949-CS (Del. Ch.) ($110 million monetary recovery for El Paso shareholders).
  • Served as one of the firm’s lead attorneys and trial counsel in MAZ Partners LP v. Bruce A. Shear, et al., No. 1:11-cv-11049 (D. Mass., 2011), a case that was tried for nine days and resulted in a post-trial verdict requiring defendants to pay $3 million in disgorgement.
  • Served as one of the firm’s lead attorneys representing a class of end-payor plaintiffs in In re Nexium (Esomeprazole) Antitrust Litigation, No. 1:12-md-02409-WGY (D. Mass.) in this pay-for-delay litigation that went to trial in 2016.
  • Served as one of the firm’s lead attorneys representing a class of foreign investors who sought to obtain green cards by investing in the Jay Peak ski resort through the Federal EB-5 Immigrant Investor Program, in Daccache v. Raymond James Financial, Inc., et al., No. 1:16-cv-21575 (S.D. Fla.), which resulted in a $150 million monetary recovery for defrauded limited partnerships.
  • Served as a member of the litigation team In re TFT-LCD (Flat Panel) Antitrust Litigation, No. M:07-cv-01827 (N.D. Cal.), which resulted in total settlements of $437 million.
  • Member of the firm’s litigation team in In re American Home Mortgage Securities Litigation, No. 07-MD-1898 (E.D.N.Y.), which settled for $37.25 million.

Community Involvement

  • Member of the Board of Directors for the Center for Insurance Research

Publications, Presentations & Appearances

Nathaniel L. Orenstein Partner
Boston
One Liberty Square
Boston, MA 02109

Nathaniel L. Orenstein is a partner in Berman Tabacco’s Boston office. He has dedicated his career to working on behalf of investors and consumers who have been harmed by improper actions by companies, their executives, and/or directors. Skilled in all phases of litigation, Nathaniel works tirelessly on behalf of his clients and the classes they represent, relishing opportunities to demonstrate corporate wrongdoing to juries at trial.

Prior to joining the firm, Nathaniel was the lead attorney on several high-profile securities fraud regulatory actions for the Securities Division of the Office of the Secretary of the Commonwealth of Massachusetts. Before that, while studying law at New York University, Nathaniel was a legal intern in the Investor Protection Bureau of the New York State Office of the Attorney General. Also, while in law school, Nathaniel was president of the Public Interest Law Foundation, raising and awarding thousands of dollars to deserving public interest projects.

Before studying law, Nathaniel was the Associate Director of the Center for Insurance Research, a consumer advocacy organization. In this role he supported complex litigation matters and advanced public policy initiatives involving insurance and banking industries and mutual holding company conversions.

Education
  • New York University School of Law (J.D., 2005)
  • Bates College (B.A., Economics, 1997)
Experience
  • Currently serves as the firm’s lead attorney representing a class of end-payor plaintiffs in In re Asacol Antitrust Litigation, No. 1:15-cv-12730-DJC (D. Mass.) in this product-hop antitrust litigation that is going to trial in late-January 2018.
  • Served as one of the firm’s lead attorneys representing institutional and individual clients in a number of cases involving mergers in which shareholders of the acquired companies received inadequate consideration. These cases include, for example: In re Bluegreen Corporation Shareholder Litigation, Case No. 502011CA018111 (Fla.) (first, increased merger consideration by $75 million, then settled for additional $36.5 million); In re TPC Group Inc. Shareholders Litigation, C.A. No. 7865 (Del. Ch.) (increased merger consideration by $79 million); In re El Paso Corporation Shareholder Litigation, C.A. No. 6949-CS (Del. Ch.) ($110 million monetary recovery for El Paso shareholders).
  • Served as one of the firm’s lead attorneys and trial counsel in MAZ Partners LP v. Bruce A. Shear, et al., No. 1:11-cv-11049 (D. Mass., 2011), a case that was tried for nine days and resulted in a post-trial verdict requiring defendants to pay $3 million in disgorgement.
  • Served as one of the firm’s lead attorneys representing a class of end-payor plaintiffs in In re Nexium (Esomeprazole) Antitrust Litigation, No. 1:12-md-02409-WGY (D. Mass.) in this pay-for-delay litigation that went to trial in 2016.
  • Served as one of the firm’s lead attorneys representing a class of foreign investors who sought to obtain green cards by investing in the Jay Peak ski resort through the Federal EB-5 Immigrant Investor Program, in Daccache v. Raymond James Financial, Inc., et al., No. 1:16-cv-21575 (S.D. Fla.), which resulted in a $150 million monetary recovery for defrauded limited partnerships.
  • Served as a member of the litigation team In re TFT-LCD (Flat Panel) Antitrust Litigation, No. M:07-cv-01827 (N.D. Cal.), which resulted in total settlements of $437 million.
  • Member of the firm’s litigation team in In re American Home Mortgage Securities Litigation, No. 07-MD-1898 (E.D.N.Y.), which settled for $37.25 million.
Honors & Distinctions
  • Named a “Rising Star” by New England Super Lawyers magazine in 2014 and 2015
Admissions
  • State Bar of Massachusetts
  • U.S. District Court for the District of Massachusetts
  • United States Court of Appeals for the First Circuit
Affiliations
  • Boston Bar Association
  • American Bar Association
Education
  • Member of the Board of Directors for the Center for Insurance Research
Publications, Presentations & Appearances